Probenecid inhibition of methotrexate excretion from cerebrospinal fluid in dogs. 1978

A Ramu, and D Glaubiger, and N P Ramu, and N Eldridge, and T F Blaschke

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D011339 Probenecid The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy. Benecid,Benemid,Benuryl,Pro-Cid,Probecid,Probenecid Weimer
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

A Ramu, and D Glaubiger, and N P Ramu, and N Eldridge, and T F Blaschke
July 1976, Cancer treatment reports,
A Ramu, and D Glaubiger, and N P Ramu, and N Eldridge, and T F Blaschke
November 1979, Clinical pharmacology and therapeutics,
A Ramu, and D Glaubiger, and N P Ramu, and N Eldridge, and T F Blaschke
January 1977, Archives internationales de pharmacodynamie et de therapie,
A Ramu, and D Glaubiger, and N P Ramu, and N Eldridge, and T F Blaschke
June 2001, The Journal of pharmacology and experimental therapeutics,
A Ramu, and D Glaubiger, and N P Ramu, and N Eldridge, and T F Blaschke
September 2001, Cancer chemotherapy and pharmacology,
A Ramu, and D Glaubiger, and N P Ramu, and N Eldridge, and T F Blaschke
November 1983, Biological psychiatry,
A Ramu, and D Glaubiger, and N P Ramu, and N Eldridge, and T F Blaschke
October 1969, Lancet (London, England),
A Ramu, and D Glaubiger, and N P Ramu, and N Eldridge, and T F Blaschke
November 1975, The New England journal of medicine,
A Ramu, and D Glaubiger, and N P Ramu, and N Eldridge, and T F Blaschke
January 1976, The New England journal of medicine,
Copied contents to your clipboard!